News
Pioneering AI Transformation from Bio to Business Intelligence. SEOUL, South Korea, July 22, 2025 /PRNewswire/ -- LG AI Research hosted its "LG AI Talk Concert 2025" today at the ...
As global markets continue to navigate a landscape of mixed economic data and trade negotiations, Asian stock markets are presenting intriguing opportunities for investors. In such an environment, ...
Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.
This University of Michigan spinout company develops ultra-small wireless smart sensors, also called Internet of Things or ...
Questex’s StreamTV Europe Announces Inaugural Advisory Board to Guide Continental Streaming Strategy
StreamTV Europe, the premier European edition of Questex’s acclaimed StreamTV Show, today unveils its inaugural Advisory ...
The life sciences industry in Westchester County comprises academic institutes doing basic research, manufacturers, and industry experts.
LG TVs are some of the most popular and high-quality around, but have you ever wondered who makes them and where they're ...
In our new webinar series, Risk Management for Your Life Sciences Company, we discuss the insurance and risk management milestones life science companies should prepare for as they move from early ...
The Life Sciences offering follows the earlier release of QBE’s Miscellaneous Medical Liability product in 2024. That product includes protection for professional liability, physical and sexual ...
AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...
ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management.
Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results